The haemodynamic effects of long term felodipine therapy in previously untreated essential hypertension

1990 ◽  
Vol 39 (6) ◽  
pp. 539-543
Author(s):  
S. Capewell ◽  
C. G. Wathen ◽  
W. J. Hannan ◽  
A. L. Muir
1990 ◽  
Vol 8 (12) ◽  
pp. 1129-1136 ◽  
Author(s):  
Per Lund-Johansen ◽  
Per Omvik ◽  
William White ◽  
??ivind Digranes ◽  
Bj??rn Helland ◽  
...  

Cardiology ◽  
1992 ◽  
Vol 80 (1) ◽  
pp. 37-45 ◽  
Author(s):  
Per Lund-Johansen ◽  
Per Omvik ◽  
William White ◽  
Øivind Digranes ◽  
Bjørn Helland ◽  
...  

1982 ◽  
Vol 14 (S2) ◽  
pp. 133S-137S ◽  
Author(s):  
BE Karlberg ◽  
J Asplund ◽  
S Wettre ◽  
KP Ohman ◽  
OR Nilsson

2002 ◽  
Vol 30 (6) ◽  
pp. 543-552 ◽  
Author(s):  
J Amerena ◽  
S Pappas ◽  
J-P Ouellet ◽  
L Williams ◽  
D O'Shaughnessy

In this multicentre, prospective, randomized, open-label, blinded-endpoint (PROBE) study, the efficacy of 12 weeks' treatment with once-daily telmisartan 40–80 mg and enalapril 10–20 mg was evaluated using ambulatory blood pressure monitoring (ABPM) in 522 patients with mild-to-moderate essential hypertension. Patients were titrated to the higher dose of study drug at week 6 if mean seated diastolic blood pressure (DBP) was ≥ 90 mmHg. The primary endpoint was the change from baseline in ambulatory DBP in the last 6 h of the 24-h dosing interval after 12 weeks' treatment. Telmisartan and enalapril produced similar reductions from baseline in DBP and systolic blood pressure (SBP) over all ABPM periods evaluated (last 6 h, 24-h, daytime and night-time). Telmisartan produced a significantly greater reduction in mean seated trough DBP, measured unblinded with an automated ABPM device in the clinic, amounting to a difference of −2.02 mmHg ( P < 0.01). A significantly greater proportion of patients achieved a seated diastolic response with telmisartan than enalapril (59% versus 50%; P < 0.05), also measured with the same ABPM device. Both treatments were well tolerated. Compared with telmisartan, enalapril was associated with a higher incidence of cough (8.9% versus 0.8%) and hypotension (3.9% versus 1.1%). Therefore, telmisartan may provide better long-term compliance and, consequently, better blood pressure control than enalapril.


1977 ◽  
Vol 05 (01) ◽  
pp. 39-44 ◽  
Author(s):  
K. Sugioka ◽  
W. Mao ◽  
J. Woods ◽  
R. A. Mueller

The effectiveness of 5 sets of acupuncture loci in decreasing systemic blood pressure was compared with chlorthalidone and propranolol in patients with essential hypertension. No statistically significant acute or long-term changes in plasma catecholamines, renin activity, or blood pressure and pulse rate were observed as a result of acupuncture treatment. The decrease in blood pressure was significantly less than the observed with propranolol, but not significantly less than produced by chlorthalidone. Because of the poor patient acceptance of acupuncture and in the absence of a beneficial response, we feel acupuncture as employed in this study is of limited value in the management of patients with essential hypertension.


1991 ◽  
Vol 14 (2) ◽  
pp. 134-140 ◽  
Author(s):  
Jürgen Hüting ◽  
Veselin Mitrovic ◽  
Jochen Thormann ◽  
Hassan Bahavar ◽  
Martin Schlepper

Sign in / Sign up

Export Citation Format

Share Document